4//SEC Filing
Zukiwski Alexander A 4
Accession 0001104659-22-098893
CIK 0000895051other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:01 PM ET
Size
6.1 KB
Accession
0001104659-22-098893
Insider Transaction Report
Form 4
Zukiwski Alexander A
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-09-07+3,000→ 3,000 totalExercise: $15.20Exp: 2031-05-25→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]On May 25, 2021, subject to approval at the June 15, 2021 shareholders meeting, the reporting person was granted these stock options that vest upon achievement of certain performance based conditions. The performance based condition was satisfied on September 7, 2022, resulting in vesting of the options.
- [F2]On June 1, 2022, the Issuer effected a 1-for-10 reverse stock split (the "Reverse Stock Split"). The number of stock options and the exercise price reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeother
Related Parties
1- filerCIK 0001569782
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:01 PM ET
- Size
- 6.1 KB